Clearside Biomedical, Inc. (CLSD)

NASDAQ: CLSD · IEX Real-Time Price · USD
0.00 (0.00%)
At close: Nov 27, 2023, 4:00 PM
+0.05 (4.95%)
After-hours: Nov 27, 2023, 7:57 PM EST

Total Valuation

CLSD has a market cap or net worth of $63.03 million. The enterprise value is $76.03 million.

Market Cap 63.03M
Enterprise Value 76.03M

Important Dates

The last earnings date was Monday, November 13, 2023, after market close.

Earnings Date Nov 13, 2023
Ex-Dividend Date n/a

Share Statistics

CLSD has 62.41 million shares outstanding. The number of shares has increased by 2.98% in one year.

Shares Outstanding 62.41M
Shares Change (YoY) +2.98%
Shares Change (QoQ) +0.53%
Owned by Insiders (%) 7.20%
Owned by Institutions (%) 27.28%
Float 53.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 28.51
Forward PS 23.94
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 34.39
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.28

Current Ratio 5.28
Quick Ratio 5.09
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -88.00%
Return on Capital (ROIC) -103.63%
Revenue Per Employee $61,417
Profits Per Employee -$1.04M
Employee Count 36
Asset Turnover 0.05
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.01% in the last 52 weeks. The beta is 2.18, so CLSD's price volatility has been higher than the market average.

Beta (1Y) 2.18
52-Week Price Change -9.01%
50-Day Moving Average 0.88
200-Day Moving Average 1.05
Relative Strength Index (RSI) 57.74
Average Volume (30 Days) 117,276

Short Selling Information

The latest short interest is 290,630, so 0.47% of the outstanding shares have been sold short.

Short Interest 290,630
Short Previous Month 344,521
Short % of Shares Out 0.47%
Short % of Float 0.54%
Short Ratio (days to cover) 2.71

Income Statement

In the last 12 months, CLSD had revenue of $2.21 million and -$37.32 million in losses. Loss per share was -$0.61.

Revenue 2.21M
Gross Profit 1.65M
Operating Income -30.00M
Pretax Income -37.32M
Net Income -37.32M
EBITDA -37.25M
EBIT -37.32M
Loss Per Share -$0.61
Full Income Statement

Balance Sheet

The company has $28.80 million in cash and $41.80 million in debt, giving a net cash position of -$12.99 million or -$0.21 per share.

Cash & Cash Equivalents 28.80M
Total Debt 41.80M
Net Cash -12.99M
Net Cash Per Share -$0.21
Equity / Book Value -12.85M
Book Value Per Share -0.21
Working Capital 24.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.24 million and capital expenditures -$1.75 million, giving a free cash flow of -$25.99 million.

Operating Cash Flow -24.24M
Capital Expenditures -1.75M
Free Cash Flow -25.99M
FCF Per Share -$0.42
Full Cash Flow Statement


Gross margin is 74.72%, with operating and profit margins of -1,356.81% and -1,687.74%.

Gross Margin 74.72%
Operating Margin -1,356.81%
Pretax Margin -1,687.74%
Profit Margin -1,687.74%
EBITDA Margin -1,684.62%
EBIT Margin -1,687.74%
FCF Margin -1,175.26%

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -59.20%
FCF Yield -41.22%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -2.98%
Shareholder Yield -2.98%

Analyst Forecast

The average price target for CLSD is $5.25, which is 419.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.25
Price Target Difference 419.80%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 126.05%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


CLSD has an Altman Z-Score of -14.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -14.7
Piotroski F-Score 1